Bio-Rad Laboratories Inc (BIO-B) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE

Key Metrics

• Price: $268.88
• Market Cap: $6.63B
• EPS: $-76.53
• 52-Week High: $265.82
• 52-Week Low: $225.29

Market Sentiment

Bio-Rad Laboratories Inc currently has a Neutral sentiment score of 0.03.

About Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. (BIO-B) stands as a premier global innovator in the life sciences and clinical diagnostics sectors, renowned for its advanced product offerings that encompass reagents, instruments, and software tailored to enhance academic and clinical research. The company's diverse portfolio is critical in driving research across genomics, proteomics, and molecular biology, solidifying its reputation as a key partner for laboratories worldwide. With a steadfast commitment to scie...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Bio-Rad Laboratories Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BIO-B pay dividends?

Bio-Rad Laboratories Inc (BIO-B) does not currently pay a regular dividend.

What is BIO-B's market cap?

Bio-Rad Laboratories Inc (BIO-B) has a market capitalization of $6.63B with a current stock price of $268.88.